| Bioactivity | BDM91288 is an orally active AcrB efflux pump inhibitor of pyridinium piperazine. BDM91288 can enhance the in vivo efficacy of levofloxacin (HY-B0330) in the treatment of Klebsiella pneumoniae pulmonary infection in mouse models[1]. |
| Name | BDM91288 |
| CAS | 2892824-53-0 |
| Formula | C17H22ClN5 |
| Molar Mass | 331.84 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Vieira Da Cruz A, et al. Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae. EMBO Mol Med. 2024 Jan;16(1):93-111. |
BDM91288
CAS: 2892824-53-0 F: C17H22ClN5 W: 331.84
BDM91288 is an orally active AcrB efflux pump inhibitor of pyridinium piperazine. BDM91288 can enhance the in vivo effic
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.